FOXO3a and the MAPK p38 are activated by cetuximab to induce cell death and inhibit cell proliferation and their expression predicts cetuximab efficacy in colorectal cancer
Marzi, L, Combes, E, Vié, N, Ayrolles-Torro, A, Tosi, D, Desigaud, D, Perez-Gracia, E, Larbouret, C, Montagut, C, Iglesias, M, Jarlier, M, Denis, V, Linares, L K, Lam, E W-F, Martineau, P, Del Rio, M,Language:
english
Journal:
British Journal of Cancer
DOI:
10.1038/bjc.2016.313
Date:
September, 2016
File:
PDF, 1.42 MB
english, 2016
File converter
More search results
More benefits 
